ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,650.27
-0.12%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cognition Therapeutics Inc (CGTX)

  7. Cognition Therapeutics Inc (CGTX) News

CGTX

Cognition Therapeutics (CGTX)

Cognition Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CGTX
DateTimeSourceHeadlineSymbolCompany
05/07/20246:45AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CGTXCognition Therapeutics Inc
05/07/20246:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
03/11/20243:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
03/11/20243:06PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CGTXCognition Therapeutics Inc
02/20/20243:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
02/20/20243:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
02/20/20243:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
02/09/20246:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
01/19/20242:07PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CGTXCognition Therapeutics Inc
01/08/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CGTXCognition Therapeutics Inc
01/08/20243:11PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:CGTXCognition Therapeutics Inc
01/04/20243:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
01/04/20246:30AMGlobeNewswire Inc.Cognition Therapeutics CEO Issues Letter to ShareholdersNASDAQ:CGTXCognition Therapeutics Inc
12/29/20233:02PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CGTXCognition Therapeutics Inc
11/16/20236:30AMGlobeNewswire Inc.Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip ScheltensNASDAQ:CGTXCognition Therapeutics Inc
11/15/20236:30AMGlobeNewswire Inc.Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s DiseasesNASDAQ:CGTXCognition Therapeutics Inc
11/13/20234:25PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CGTXCognition Therapeutics Inc
11/13/20234:17PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
11/13/20238:48AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
11/13/20238:47AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
11/07/20236:30AMGlobeNewswire Inc.Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s DiseaseNASDAQ:CGTXCognition Therapeutics Inc
11/02/20236:45AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CGTXCognition Therapeutics Inc
11/02/20236:41AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
11/02/20236:30AMGlobeNewswire Inc.Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CGTXCognition Therapeutics Inc
10/27/20236:30AMGlobeNewswire Inc.Cognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation on the START Study in Early Alzheimer’s Disease at CTADNASDAQ:CGTXCognition Therapeutics Inc
10/24/20233:30PMGlobeNewswire Inc.Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at CTADNASDAQ:CGTXCognition Therapeutics Inc
10/16/20236:30AMGlobeNewswire Inc.Cognition Therapeutics Presents New Data at CTAD Conference from Advancing Pipeline Across Multiple CNS IndicationsNASDAQ:CGTXCognition Therapeutics Inc
09/12/20236:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
09/07/20236:45AMGlobeNewswire Inc.Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMDNASDAQ:CGTXCognition Therapeutics Inc
08/30/20237:00AMGlobeNewswire Inc.Cognition Therapeutics Announces Participation in Upcoming September ConferencesNASDAQ:CGTXCognition Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CGTX

Your Recent History

USOTC
PHIL
PHI (PK)
NASDAQ
DJT
Trump Media and Technology
NASDAQ
COOP
Mr Cooper
USOTC
RNVA
Rennova Health (PK)
USOTC
RDGL
Vivos (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
NVDA
NVIDIA
NASDAQ
LWLG
Lightwave Logic
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
CYDY
CytoDyn (QB)
NYSE
AMC
AMC Entertainment
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
NB
NioCorp Developments
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved